Catalent Inc (CTLT)
60.59
-0.12
(-0.20%)
USD |
NYSE |
Oct 04, 16:00
60.55
-0.04
(-0.07%)
After-Hours: 20:00
Catalent Shareholders Equity (Annual): 3.604B for June 30, 2024
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| June 30, 2024 | 3.604B |
| June 30, 2023 | 4.611B |
| June 30, 2022 | 4.775B |
| June 30, 2021 | 4.274B |
| June 30, 2020 | 3.506B |
| June 30, 2019 | 2.288B |
| June 30, 2018 | 1.087B |
| Date | Value |
|---|---|
| June 30, 2017 | 723.50M |
| June 30, 2016 | 635.90M |
| June 30, 2015 | 634.00M |
| June 30, 2014 | -371.20M |
| June 30, 2013 | -410.70M |
| June 30, 2012 | -350.70M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
3.506B
Minimum
2020
4.775B
Maximum
2022
4.154B
Average
4.274B
Median
2021
Shareholders Equity (Annual) Benchmarks
| United Therapeutics Corp | 5.985B |
| The Cooper Companies Inc | 7.551B |
| Johnson & Johnson | 68.77B |
| Eli Lilly and Co | 10.77B |
| BioCardia Inc | -1.603M |